J., Iranmanesh, A., & Veldhuis, J
Additionally, both semaglutide and tirzepatide showed promise in improving metabolic dysfunction-associated steatotic liver disease (MASLD), mitigating systemic inflammation, and contributing to improvements in liver-related outcomes, including steatosis resolution and fibrosis-related endpoints, in clinical trials
\Cardiovascular Protection: 50% reduction in cardiovascular mortality over 12 years (Human Study)
Regardless of gender, semaglitude therapy improved heart failure-related symptoms, exercise function, physical constraints, inflammation, and natriuretic peptides
Initiation of semaglutide therapy Patient Profile 56-year-old female Hgb A1C 8% Blood pressure 138/86 Fasting glucose 150 Social/ Lifestyle history Single/ Lives alone Sedentary work The diet contains significant amounts of processed foods No regular physical activity (I try to go for a walk some days at lunch time) High School graduate Chief Complaint: Im having a hard time controlling my blood sugar levels
If you forget to take it for a few days, simply continue with your regular dosage as soon as you remember